EMAIL: mattl@mjbizdaily.com
PHONE: 720.699.0794

Matt Lamers

Matt is based in the Greater Toronto Area and covers international cannabis markets for Marijuana Business Daily. Previously, he worked as a business editor, photographer and reporter for newspapers and magazines in three countries, covering everything from the oil and gas industry in northern British Columbia to North Korean defectors in Seoul.

Vancouver MMJ dispensary to get its day in court – in a year

A date finally has been set for a British Columbia courtroom to hear a case involving the first of 53 injunctions Vancouver has filed against unlicensed medical marijuana dispensaries operating within the city. Karuna Health Foundation will serve as a “test case” for the other 52 injunctions, CBC News reported, although the case won’t be heard for […]

Read More

Canadian firm buys Florida land to boost medical marijuana output

The Canadian holder of a license to cultivate medical marijuana in Florida plans to expand its production capacity in the state by more than 35 times to capitalize on the launch of the Sunshine State’s full-fledged MMJ market. Liberty Health Sciences, which is based in Toronto and trades on the Canadian Securities Exchange under the […]

Read More

Canada’s Canopy Growth expects to use mail for rec marijuana sales

One of Canada’s largest licensed medical marijuana producers doubts all the provinces will have networks of retail MJ stores ready for takeoff when the country legalizes recreational cannabis next summer – and so the company is readying its own mail-order platform. Canopy Growth believes the majority of its sales in the first two years of […]

Read More

Aphria invests in Scientus to tap Canadian MJ extracts market

Aphria is increasing its stake in the booming cannabinoid-based extracts market with an 11.5 million Canadian dollar ($9 million) investment in Scientus Pharma, a vertically integrated biopharmaceutical company. Toronto-based Scientus Pharma conducts research and product development related to medical cannabinoids and their derivatives. The investment is in the form of senior, secured convertible debt. Aphria […]

Read More

Canadian execs: What you need to know before taking your cannabis business global

By Matt Lamers

There’s no denying the massive potential of the global medical marijuana market: A recent report pegged it at 180 billion Canadian dollars ($142 billion) over the next 15 years.

But going overseas is fraught with pitfalls, barriers and red tape. Canadian MMJ businesses, however, are export pioneers and can offer valuable guidance.

Read More

Quebec to consult public on recreational cannabis legalization

After consulting experts on the production, distribution and sale of recreational marijuana, Quebec is asking the public to weigh in on a range of issues that will guide Canada’s second-largest province in developing MJ legislation to be offered this fall. From Aug. 21 to Sept. 12, the public is invited to submit feedback by filing […]

Read More

Aphria teaming with Nuuvera to build large Ontario greenhouse

One of Canada’s biggest cannabis cultivators, Aphria Inc., is partnering with an upstart Canadian producer to build a 1 million-square-foot MJ greenhouse in the Ontario town of Leamington. Aphria (TSE: APH) said in a news release it also is pumping 2 million Canadian dollars ($1.6 million) into its new partner, Nuverra Corp., through a share purchase. Nuuvera […]

Read More

Applications open for Canadian marijuana business accelerator

Budding cannabis entrepreneurs in Canada have a new resource to help get their businesses launched, thanks to some established players in the nation’s marijuana industry. Leaf Forward, which claims to be the country’s first cannabis business accelerator program, will provide early stage ancillary businesses with mentoring, networking and learning opportunities. The program doesn’t provide seed […]

Read More

Medical marijuana companies in Canada capitalizing on ‘insane’ growth abroad

By Matt Lamers

Canadian medical marijuana companies are primed to tap what one industry executive calls “insane” growth overseas.

Flush with capital and largely free from American competition, Canadian licensed producers are spreading their wings to gain a first-mover advantage in new markets as more countries legalize marijuana for medical use.

Read More